Today: 28 June 2026

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Genting Singapore stock price holds at S$0.73 — what could move SGX:G13 next week

Genting Singapore stock price holds at S$0.73 — what could move SGX:G13 next week

Genting Singapore closed flat at S$0.730 on Friday, with 33.6 million shares traded as the Straits Times Index hit a record high. The stock moved between S$0.725 and S$0.735 during the session. The company will report full-year results on Feb. 24 after market close. Resorts World Sentosa’s casino licence was renewed for two years amid concerns over tourism figures.
24 January 2026
··
Keppel stock price: Bifrost fibre deal keeps BN4 in focus ahead of February earnings

Keppel stock price: Bifrost fibre deal keeps BN4 in focus ahead of February earnings

Keppel shares rose 1.2% to S$11.02 Friday after the company signed a 25-year term sheet with a global telecom for a fibre pair on its Bifrost subsea cable. The deal, described as an “indefeasible right of use,” is expected to be finalized by Q2 2026. Keppel said the agreement will not significantly impact this year’s earnings. Investors await Keppel’s full-year results on February 5.
24 January 2026
··
South32 share price set for Tuesday test after UBS upgrade and fresh quarterly update

South32 share price set for Tuesday test after UBS upgrade and fresh quarterly update

South32 shares fell 0.23% to A$4.39 Friday after a 5.26% surge the previous day, closing near a 52-week high. UBS upgraded the stock to “buy” and raised its price target, citing improved operations. The ASX will close Monday for Australia Day, delaying South32’s next local session until Tuesday. Half-year results are due Feb. 12, with an interim dividend decision expected the same day.
24 January 2026
NAB share price: fixed mortgage-rate hike keeps CPI and RBA in focus as ASX shuts for long weekend

NAB share price: fixed mortgage-rate hike keeps CPI and RBA in focus as ASX shuts for long weekend

NAB shares closed down 0.2% at A$42.35 Friday after the bank raised fixed mortgage rates by up to 0.40 percentage points. The ASX will remain shut until Tuesday for the Australia Day holiday. Strong jobs data and shifting rate expectations have heightened focus on the upcoming inflation report and the RBA’s February 3 policy decision.
24 January 2026
···
Lynas Rare Earths share price: ASX:LYC ends the week higher as price-floor talk returns — what to watch next

Lynas Rare Earths share price: ASX:LYC ends the week higher as price-floor talk returns — what to watch next

Lynas Rare Earths closed Friday up 0.7% at A$16.86, capping a 9% weekly gain after reporting a 43% jump in quarterly sales revenue on higher prices, despite output falling to 2,382 tons due to power outages at its Kalgoorlie plant. CEO Amanda Lacaze said policy support is helping, as governments discuss price floors for rare earths. The ASX reopens Tuesday after the Australia Day holiday.
24 January 2026
··
Macquarie stock price slips into holiday week as filings flag stake shifts — here’s what matters next

Macquarie stock price slips into holiday week as filings flag stake shifts — here’s what matters next

Macquarie Group shares slipped 0.2% to A$210.41 at Friday’s close. Company filings showed Macquarie entities became a substantial holder in Beetaloo Energy, crossing the 5% mark, but fell below 5% in Pantoro Gold. Investors await Australia’s CPI data and the U.S. Fed’s decision on Jan. 28. The next ASX session follows a public holiday, narrowing reaction time to any market shocks.
24 January 2026
···
1 … 173 174 175 176 177 … 596

Stock Market Today

  • Globus Medical (GMED) Stock Posts 47% Gain, Valuation Indicates Further Upside
    June 27, 2026, 10:51 PM EDT. Globus Medical (GMED) shares have surged 47.2% over the past year, driven by its role in the medical devices sector. Despite recent price fluctuations, the stock trades at around $86.25, significantly below its intrinsic value. A Discounted Cash Flow (DCF) analysis values the stock at approximately $160.09 per share, indicating it is undervalued by about 46%. The DCF model projects growing free cash flows, rising from $620.8 million last year to over $1.2 billion by 2035. This suggests the current market price offers potential upside for investors, supported by a 6/6 value score from Simply Wall St. Investors should consider these valuation metrics in the context of industry trends and long-term growth prospects before making investment decisions.

Latest articles

Hecla Mining (NYSE:HL) sees stock rebound, volume jumps as silver prices in focus

Hecla Mining (NYSE:HL) sees stock rebound, volume jumps as silver prices in focus

28 June 2026
Hecla Mining surged 5.3 times its average trading volume Friday as index rebalancing drove 112.44 million shares traded, but the stock’s 2.6% weekly drop still beat silver and peer ETFs, signaling company-specific strength; investors now watch if Hecla can hold above $15.54 without rebalancing flows as macro risks loom.
Go toTop